XML 31 R15.htm IDEA: XBRL DOCUMENT
v3.25.4

Earnings Per Share | 12 Months Ended
--- | ---
Dec. 31, 2025
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share
| Year Ended December 31,
(in millions, except per share amounts) | 2025 | 2024 | 2023
Net earnings (loss) attributable to Fluor | $ | (51) |  | $ | 2,145 |  | $ | 139 |
Less: Dividends on CPS | — |  | — |  | 29 |
Less: Make-whole payment on conversion of CPS | — |  | — |  | 27 |
Net earnings (loss) available to Fluor common stockholders | $ | (51) |  | $ | 2,145 |  | $ | 83 |
Weighted average common shares outstanding | 164 |  | 172 |  | 150 |
Dilutive effect: |  |  |
Performance-based award units, RSUs and stock options | — |  | 2 |  | 3 |
Convertible debt (1) | — |  | — |  | — |
Weighted average diluted shares outstanding | 164 |  | 174 |  | 153 |
Basic EPS available to Fluor common stockholders | $ | (0.31) |  | $ | 12.48 |  | $ | 0.55 |
Diluted EPS available to Fluor common stockholders | $ | (0.31) |  | $ | 12.30 |  | $ | 0.54 |
Anti-dilutive securities not included in shares outstanding: |  |  |
CPS | — |  | — |  | 20 |
Performance-based award units, RSUs and stock options | 3 |  | 1 |  | 2 |
Stock delivered under capped call options (2) | — |  | — |  | — |
(1) Holders of our 2029 Notes may convert their notes at a conversion price of $45.37 per share when the stock price exceeds $58.98 for 20 of the last 30 days preceding quarter end. Upon conversion, we will repay the principal amount of the notes in cash and may elect to convey the conversion premium in cash, shares of our common stock or a combination of both. The conversion feature of our 2029 Notes has a dilutive impact on EPS when the average market price of our common stock exceeds the conversion price of $45.37 per share for the quarter. During 2025 and 2023, the weighted average price of our common stock was below the minimum conversion price. During 2024, the weighted average price of our common stock exceeded $45.37 resulting in the addition of 575,000 shares to diluted shares outstanding. (2) Diluted shares outstanding does not include the impact of the capped call options we entered into concurrently with the issuance of the 2029 Notes, as the effect is always anti-dilutive. If shares are delivered to us under the capped calls, those shares will offset the dilutive effect of the shares that we would issue upon conversion of the 2029 Notes.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration